Alken Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
PI
PCM
LTI
RA
CWM
Alken Asset Management's BSX.PRA Position: Q4 2020 in Review
Alken Asset Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2020, closing a stake of 3,900 shares — an estimated $436K sold.
Alken Asset Management first reported a position in BSX.PRA in Q3 2020 and held it in 1 quarter. The position peaked at $436K in Q3 2020. 7 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2020.
- Alken Asset Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2020 after selling out during the quarter.
- Alken Asset Management sold 3,900 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2020, an estimated $436K.
- Alken Asset Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2020 and held it in 1 quarter.
- Alken Asset Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $436K in Q3 2020.
- 7 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2020.
Based on Alken Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.